Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP35784.RACZQOX-Zp0cxkYnpLNuN2F9LJnj2wzR2OV3dzUoNIItc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP35784.RACZQOX-Zp0cxkYnpLNuN2F9LJnj2wzR2OV3dzUoNIItc130_assertion type Assertion NP35784.RACZQOX-Zp0cxkYnpLNuN2F9LJnj2wzR2OV3dzUoNIItc130_head.
- NP35784.RACZQOX-Zp0cxkYnpLNuN2F9LJnj2wzR2OV3dzUoNIItc130_assertion description "[Pharmacological characterization of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103), a novel selective 5-lipoxygenase-activating protein inhibitor that reduces acute and chronic inflammation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP35784.RACZQOX-Zp0cxkYnpLNuN2F9LJnj2wzR2OV3dzUoNIItc130_provenance.
- NP35784.RACZQOX-Zp0cxkYnpLNuN2F9LJnj2wzR2OV3dzUoNIItc130_assertion evidence source_evidence_predicted NP35784.RACZQOX-Zp0cxkYnpLNuN2F9LJnj2wzR2OV3dzUoNIItc130_provenance.
- NP35784.RACZQOX-Zp0cxkYnpLNuN2F9LJnj2wzR2OV3dzUoNIItc130_assertion SIO_000772 19749079 NP35784.RACZQOX-Zp0cxkYnpLNuN2F9LJnj2wzR2OV3dzUoNIItc130_provenance.
- NP35784.RACZQOX-Zp0cxkYnpLNuN2F9LJnj2wzR2OV3dzUoNIItc130_assertion wasDerivedFrom rgd-20130729 NP35784.RACZQOX-Zp0cxkYnpLNuN2F9LJnj2wzR2OV3dzUoNIItc130_provenance.
- NP35784.RACZQOX-Zp0cxkYnpLNuN2F9LJnj2wzR2OV3dzUoNIItc130_assertion wasGeneratedBy ECO_0000218 NP35784.RACZQOX-Zp0cxkYnpLNuN2F9LJnj2wzR2OV3dzUoNIItc130_provenance.